Low Philip S 4

Accession 0001179110-18-014132

CIK 0001235007other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:13 PM ET

Size

37.1 KB

Accession

0001179110-18-014132

Insider Transaction Report

Form 4

Period: 2018-12-17

ENDOCYTE INCECYT

Low Philip S

DirectorChief Science Officer

Transactions

Exercise/Conversion
Stock option (right to buy)
2018-12-17−9,000→ 36,000 total
Exercise: $11.11Exp: 2024-02-06→ Common Stock (9,000 underlying)
Gift
Common Stock
2018-12-12−52,346→ 269,204 total
Exercise/Conversion
Common Stock
2018-12-17$11.80/sh+2,050$24,190→ 367,854 total
Exercise/Conversion
Common Stock
2018-12-17$11.11/sh+9,000$99,990→ 409,940 total
Exercise/Conversion
Common Stock
2018-12-17$5.10/sh+2$10→ 409,942 total
Exercise/Conversion
Common Stock
2018-12-17$3.18/sh+2$6→ 409,944 total
Exercise/Conversion
Stock Option (right to buy)
2018-12-17−21,440→ 8,560 total
Exercise: $9.05Exp: 2021-04-14→ Common Stock (21,440 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−20,004→ 59,996 total
Exercise: $3.55Exp: 2022-02-28→ Common Stock (20,004 underlying)
Exercise/Conversion
Common Stock
2018-12-17$3.82/sh+51,875$198,163→ 344,364 total
Exercise/Conversion
Common Stock
2018-12-17$9.05/sh+21,440$194,032→ 365,804 total
Exercise/Conversion
Common Stock
2018-12-17$3.55/sh+20,004$71,014→ 387,858 total
Exercise/Conversion
Stock Option (right to buy)
2018-12-17−51,875→ 13,570 total
Exercise: $3.82Exp: 2020-02-11→ Common Stock (51,875 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−2,050→ 17,950 total
Exercise: $11.80Exp: 2021-05-26→ Common Stock (2,050 underlying)
Gift
Common Stock
2018-12-12−52,512→ 132,473 total(indirect: By Trust)
Exercise/Conversion
Common Stock
2018-12-17$2.54/sh+22,759$57,808→ 292,489 total
Exercise/Conversion
Common Stock
2018-12-17$9.86/sh+13,082$128,989→ 400,940 total
Exercise/Conversion
Stock Option (right to buy)
2018-12-17−22,759→ 0 total
Exercise: $2.54Exp: 2019-03-05→ Common Stock (22,759 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−13,082→ 56,918 total
Exercise: $9.86Exp: 2023-02-19→ Common Stock (13,082 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−2→ 52,498 total
Exercise: $5.10Exp: 2025-02-04→ Common Stock (2 underlying)
Exercise/Conversion
Stock option (right to buy)
2018-12-17−2→ 52,498 total
Exercise: $3.18Exp: 2026-02-04→ Common Stock (2 underlying)

Footnotes (5)

[F1]Represents gifts of 52,512 shares by Spouse Trust to non-profit organizations.
[F2]Represents a gift of 52,346 shares to a non-profit organization.
[F3]Includes 526 shares acquired under the 2010 Endocyte, Inc. Employee Stock Purchase Plan on December 14, 2018.
[F4]The option is fully vested and immediately exercisable.
[F5]Shares subject to this option vest 1/4 annually over a period of four years beginning February 4, 2017.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ENDOCYTE INC

CIK 0001235007

→

Entity typeother

Related Parties

filerCIK 0001509669

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 4:13 PM ET
Size: 37.1 KB

View on SEC.gov